{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:03:30Z","timestamp":1792181010683,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ejphar.2007.01.028","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T22:24:27Z","timestamp":1170455067000},"page":"1-8","source":"Crossref","is-referenced-by-count":184,"title":["The neuronal 5-HT3 receptor network after 20\u00a0years of research \u2014 Evolving concepts in management of pain and inflammation"],"prefix":"10.1016","volume":"560","author":[{"given":"Lothar","family":"Faerber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Drechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ladenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Gschaidmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.01.028_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00132576-200209000-00001","article-title":"Ondansetron with and without naltrexone as a treatment of biologic alcoholism: concepts and updated findings","volume":"1","author":"Ait-Daoud","year":"2002","journal-title":"Addict. Disord. Treat."},{"key":"10.1016\/j.ejphar.2007.01.028_bib2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1523\/JNEUROSCI.11-07-01881.1991","article-title":"Spinal 5-HT3-mediated anti-nociception \u2014 possible release of GABA","volume":"11","author":"Alhaider","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.01.028_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3940(95)12600-7","article-title":"The role of 5HT3 in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies","volume":"208","author":"Ali","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.01.028_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2007-995902","article-title":"Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockade","volume":"31","author":"Alon","year":"1996","journal-title":"Anasthesiol. Intensivmed. Notfallmed. Schmerzther."},{"key":"10.1016\/j.ejphar.2007.01.028_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ddr.430310310","article-title":"Effect produced by acute and chronic administration of the selective 5-HT-3 receptor antagonist BRL 46470 on the number of spontaneously active midbrain dopamine cells in the rat","volume":"31","author":"Ashby","year":"1994","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib6","doi-asserted-by":"crossref","first-page":"12595","DOI":"10.1073\/pnas.0503253102","article-title":"Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors","volume":"102","author":"Barrera","year":"2005","journal-title":"PNAS"},{"issue":"No. 3, Suppl","key":"10.1016\/j.ejphar.2007.01.028_bib7","first-page":"A30","article-title":"Effects of the 5-HT3 receptor agonist SR 57227A and antagonist Y-25130 on the behaviour of rats in the elevated zero-maze model of anxiety","volume":"17","author":"Bell","year":"2003","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.ejphar.2007.01.028_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/gast.2002.35990","article-title":"Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron","volume":"123","author":"Berman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2007.01.028_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/mcne.2002.1160","article-title":"Assembly and cell surface expression of homomeric and heteromeric 5-HT3 receptors: the role of oligomerization and chaperone proteins","volume":"21","author":"Boyd","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2007.01.028_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1055\/s-2005-870323","article-title":"Hyperglycemia induced by pharmacological activation of central serotonergic pathways depends on the functional integrity of brain CRH system and 5-HT3 receptors","volume":"37","author":"Carvalho","year":"2005","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuroscience.2005.02.013","article-title":"Transmitter content, origins and connections of axons in the spinal cord that possess the serotonin (5-hydroxytryptamine) 3 receptor","volume":"134","author":"Conte","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.01.028_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1526-4610.1991.hed3105296.x","article-title":"First clinical study of the selective 5-HT3 antagonist, granisetron (BRL 43694), in the acute treatment of migraine headache","volume":"31","author":"Couturier","year":"1991","journal-title":"Headache"},{"key":"10.1016\/j.ejphar.2007.01.028_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molbrainres.2003.09.003","article-title":"The 5-HT3B subunit confers reduced sensitivity to picrotoxin when co-expressed with the 5-HT3A receptor","volume":"119","author":"Das","year":"2003","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bcp.2005.04.031","article-title":"The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway","volume":"70","author":"De la Vega","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.mp.4001314","article-title":"Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor","volume":"8","author":"Eisensamer","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.01.028_bib16","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1523\/JNEUROSCI.2460-05.2005","article-title":"Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains","volume":"25","author":"Eisensamer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.01.028_bib17","first-page":"1","article-title":"Short-term treatment of primary fibromyalgia with the 5-HT3 receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients","volume":"21","author":"Faerber","year":"2001","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0304-3959(98)00108-0","article-title":"Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviours and pain thresholds","volume":"77","author":"Faris","year":"1998","journal-title":"Pain"},{"issue":"S3","key":"10.1016\/j.ejphar.2007.01.028_bib19","first-page":"56","article-title":"Radiotherapy-induced emesis. An overview","volume":"174","author":"Feyer","year":"1998","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/03009740410006998","article-title":"Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes","volume":"33","author":"Fiebich","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1358\/mf.2004.26.8.863726","article-title":"Activation of presynaptic 5-HT3 receptors facilitates glutamatergic synaptic input to area postrema neurons in rat brain slices","volume":"26","author":"Funahashi","year":"2004","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00169258","article-title":"Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine","volume":"347","author":"Gebauer","year":"1993","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib23","first-page":"357","article-title":"Involvement of some 5-ht receptors in methamphetamine-induced locomotor activity in mice","volume":"55","author":"Ginawi","year":"2004","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.phrs.2004.09.002","article-title":"Ondansetron, a selective 5-HT3 receptor antagonist, antagonizes methamphetamine-induced anorexia in mice","volume":"51","author":"Ginawi","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003495-199753010-00003","article-title":"The non-antiemetic uses of serotonin 5-HT3 receptor antagonists","volume":"53","author":"Greenshaw","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2007.01.028_bib26","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0006-3495(03)74980-7","article-title":"Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor","volume":"84","author":"Hapfelmeier","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2007.01.028_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2006.03.018","article-title":"Gastric distension enhances CCK-induced Fos-like immunoreactivity in the dorsal hindbrain by activating 5-HT3 receptors","volume":"1088","author":"Hayes","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0301-0082(99)00051-9","article-title":"Wind-up of spinal cord neurones and pain sensation: much ado about something?","volume":"61","author":"Herrero","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.neuropharm.2004.06.015","article-title":"Potentiation of 5-HT3 receptor function by the activation of coexistent 5-HT2 receptors in trigeminal ganglion neurons of rats","volume":"47","author":"Hu","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.01.028_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0028-3908(95)00033-3","article-title":"Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex","volume":"34","author":"Ito","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.01.028_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03009740410007096","article-title":"The assessment of vegetative and functional symptoms in fibromyalgia patients: the tropisetron experience","volume":"33","author":"Kohnen","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib32","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/01.ALC.0000075547.77464.76","article-title":"Effects of ondansetron in early-versus late-onset alcoholics: a prospective, open-label study","volume":"27","author":"Kranzler","year":"2003","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02247373","article-title":"A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder","volume":"112","author":"Lecrubier","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.01.028_bib34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0026-895X(24)05657-8","article-title":"Acetaminophen: a central analgesic drug that involves a spinal tropisetron-sensitive, non-5-HT3 receptor-mediated effect","volume":"66","author":"Libert","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1468-2982.1985.0502079.x","article-title":"Effects on migraine headache of MDL 72222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study","volume":"5","author":"Loisy","year":"1985","journal-title":"Cephalagia"},{"key":"10.1016\/j.ejphar.2007.01.028_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0028-3908(99)00164-1","article-title":"Ethanol and trichloroethanol alter gating of 5-HT3 receptor-channels in NCB-20 neuroblastoma cells","volume":"39","author":"Lovinger","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.01.028_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0960-894X(00)00670-3","article-title":"The 5-HT3 antagonist tropisetron (ICS 205\u2013930) is a potent and selective alpha7 nicotinic receptor partial agonist","volume":"11","author":"Macor","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2007.01.028_bib38","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.1365-2036.2002.01287.x","article-title":"The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients","volume":"16","author":"Mayer","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.01.028_bib39","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1213\/01.ANE.0000085640.69855.51","article-title":"Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study","volume":"97","author":"McCleane","year":"2003","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2007.01.028_bib40","first-page":"891","article-title":"Studies on ondansetron in schizophrenia","volume":"2","author":"Meltzer","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.01.028_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ddr.430280111","article-title":"Pharmacological properties of dolasetron, a potent and selective antagonist at 5-HT3 receptors","volume":"28","author":"Miller","year":"1993","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.0953-816x.2001.01872.x","article-title":"Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system","volume":"15","author":"Miquel","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.01.028_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0006-8993(02)04197-5","article-title":"Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors","volume":"966","author":"Moennikes","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib44","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1152\/japplphysiol.00974.2001","article-title":"5-HT(3) receptors mediate inflammation-induced unmasking of functional tachykinin responses in vitro","volume":"92","author":"Moore","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cne.1307","article-title":"5-HT(3)-receptor subunits A and B are co-expressed in neurons of the dorsal root ganglion","volume":"438","author":"Morales","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib47","first-page":"59","article-title":"Results of the intravenous administration of tropisetron in fibromyalgia patients","volume":"113","author":"Mueller","year":"2001","journal-title":"Scand. J. Rheumatol., Suppl."},{"key":"10.1016\/j.ejphar.2007.01.028_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/03009740410007032","article-title":"Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron","volume":"33","author":"Mueller","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(03)00503-1","article-title":"Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E","volume":"310","author":"Niesler","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.ejphar.2007.01.028_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.6154313","article-title":"Substance P: does it produce analgesia or hyperalgesia?","volume":"208","author":"Oehme","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2007.01.028_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2004.12.025","article-title":"Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist","volume":"378","author":"Papke","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.01.028_bib51","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/00001756-199507310-00020","article-title":"Evidence of a central antinociceptive effect of paracetamol involving spinal 5-HT3 receptors","volume":"6","author":"Pelissier","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.ejphar.2007.01.028_bib52","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.2004.055251","article-title":"Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study","volume":"54","author":"Piche","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2007.01.028_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-2999(90)90425-6","article-title":"Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its \u00ae and (S) enantiomers","volume":"179","author":"Pinkus","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib54","series-title":"Recent Advances in the Treatment of Neurodegenerative Disorders and Cognitive Dysfunction","first-page":"89","article-title":"5-HT3 antagonists and disorders of cognition","volume":"vol. 7","author":"Preston","year":"1994"},{"key":"10.1016\/j.ejphar.2007.01.028_bib55","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.mp.4001490","article-title":"Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner","volume":"9","author":"Rammes","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.01.028_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbr.2004.05.003","article-title":"Serotonin type 3 receptors stimulate offensive aggression in Syrian hamsters","volume":"156","author":"Ricci","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.01.028_bib57","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1471-4159.1998.70031094.x","article-title":"High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum","volume":"70","author":"Ronde","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.01.028_bib58","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/mol.63.5.1067","article-title":"Direct interaction of serotonin type 3 receptor ligands with recombinant and native alpha 9 alpha 10-containing nicotinic cholinergic receptors","volume":"63","author":"Rothlin","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/03009740410007050","article-title":"Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone","volume":"33","author":"Samborski","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00001756-199010000-00005","article-title":"5-HT3-receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord","volume":"1","author":"Saria","year":"1990","journal-title":"NeuroReport"},{"key":"10.1016\/j.ejphar.2007.01.028_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/03009740410007014","article-title":"Immunomodulatory function of the 5-HT3 receptor antagonist tropisetron","volume":"33","author":"Schneider","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/j.0001-6349.2004.00556.x","article-title":"Cholestasis of pregnancy, pruritus and 5-hydroxytryptamine 3 receptor antagonists","volume":"83","author":"Schumann","year":"2004","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ejphar.2007.01.028_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/03009740410007005","article-title":"Tropisetron inhibits serotonin-induced PGE2 release from macrophage-like synovial cells in serum-free tissue culture","volume":"33","author":"Seidel","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/030097400446698","article-title":"Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists \u2014 preliminary results","volume":"29","author":"Spaeth","year":"2000","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/03009740410007078","article-title":"Treatment of systemic sclerosis with the 5-HT3 receptor antagonist tropisetron","volume":"33","author":"Stratz","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/03009740410007023","article-title":"Influence of tropisetron on the serum substance P levels in fibromyalgia patients","volume":"33","author":"Stratz","year":"2004","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib67","first-page":"150","article-title":"Modulation of 5-HT3 receptor-mediated response and trafficking by activation of protein kinase C","volume":"34","author":"Sun","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.01.028_bib68","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000542-200203000-00028","article-title":"The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in Xenopus oocytes","volume":"96","author":"Suzuki","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2007.01.028_bib69","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1254\/jjp.78.511","article-title":"Serotonin receptor subtypes involved in modulation of electrical acupuncture","volume":"78","author":"Tagaki","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib70","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.90.4.1430","article-title":"Nervous system distribution of the serotonin 5-HT3 receptor mRNA","volume":"90","author":"Tecott","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.01.028_bib71","first-page":"175","article-title":"Multiple serotonin receptor subtypes: molecular cloning and functional expression","volume":"8","author":"Teitler","year":"1994","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib72","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuroscience.2004.08.020","article-title":"Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies","volume":"129","author":"Turner","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.01.028_bib73","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.0906-6705.2004.00184.x","article-title":"Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients","volume":"13","author":"Weisshaar","year":"2004","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00280-004-0798-x","article-title":"Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT3 receptor antagonists in cancer patients","volume":"54","author":"Yamada","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.01.028_bib75","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1523\/JNEUROSCI.22-03-01010.2002","article-title":"The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors","volume":"22","author":"Zeitz","year":"2002","journal-title":"J. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T08:19:38Z","timestamp":1736756378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0014299907000179"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.01.028","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}